Plus Therapeutics, Inc.
PSTV
$0.26
$0.00-1.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.17% | -185.87% | 129.60% | -345.84% | -35.80% |
| Total Depreciation and Amortization | 88.31% | 0.00% | -47.26% | -58.05% | 74.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.30% | 108.26% | -152.10% | 139,222.22% | 98.94% |
| Change in Net Operating Assets | -207.94% | 127.96% | -213.14% | -160.60% | 1,621.15% |
| Cash from Operations | -145.57% | 56.05% | 6.06% | -409.66% | 67.09% |
| Capital Expenditure | -11.11% | -285.71% | -133.33% | 72.73% | 21.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -179.08% | 128.63% | -230.98% | 4,608.00% | 1,400.00% |
| Cash from Investing | -183.04% | 128.00% | -230.19% | 5,459.38% | 811.11% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -82.20% | 459.05% | -80.74% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.16% | -1,970.00% | -- | -- | -- |
| Cash from Financing | -77.22% | 340.16% | -77.46% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.98% | 244.83% | -177.97% | 953.62% | 68.91% |